DE3249568A1 - Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs - Google Patents

Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs

Info

Publication number
DE3249568A1
DE3249568A1 DE19823249568 DE3249568A DE3249568A1 DE 3249568 A1 DE3249568 A1 DE 3249568A1 DE 19823249568 DE19823249568 DE 19823249568 DE 3249568 A DE3249568 A DE 3249568A DE 3249568 A1 DE3249568 A1 DE 3249568A1
Authority
DE
Germany
Prior art keywords
gra
lectin
cancer
cells
related antigen
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
DE19823249568
Other languages
German (de)
English (en)
Other versions
DE3249568C2 (OSRAM
Inventor
Masakazu Takasaki Adachi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Otsuka Pharmaceutical Co Ltd
Original Assignee
Otsuka Pharmaceutical Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP15641481A external-priority patent/JPS5857321A/ja
Priority claimed from JP56156413A external-priority patent/JPS5857318A/ja
Priority claimed from JP56158473A external-priority patent/JPS5859923A/ja
Priority claimed from JP56158472A external-priority patent/JPS5859922A/ja
Priority claimed from JP57111168A external-priority patent/JPS591420A/ja
Application filed by Otsuka Pharmaceutical Co Ltd filed Critical Otsuka Pharmaceutical Co Ltd
Publication of DE3249568A1 publication Critical patent/DE3249568A1/de
Application granted granted Critical
Publication of DE3249568C2 publication Critical patent/DE3249568C2/de
Granted legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/0005—Vertebrate antigens
    • A61K39/0011—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/515—Animal cells
    • A61K2039/5158—Antigen-pulsed cells, e.g. T-cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Oncology (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Steroid Compounds (AREA)
DE19823249568 1981-10-01 1982-09-30 Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs Granted DE3249568A1 (de)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
JP15641481A JPS5857321A (ja) 1981-10-01 1981-10-01 抗癌剤
JP56156413A JPS5857318A (ja) 1981-10-01 1981-10-01 癌細胞障害性リンパ球の製造法
JP56158473A JPS5859923A (ja) 1981-10-05 1981-10-05 抗癌剤
JP56158472A JPS5859922A (ja) 1981-10-05 1981-10-05 癌細胞障害性リンパ球
JP57111168A JPS591420A (ja) 1982-06-28 1982-06-28 糖鎖関連抗原およびその製造法

Publications (2)

Publication Number Publication Date
DE3249568A1 true DE3249568A1 (de) 1985-02-07
DE3249568C2 DE3249568C2 (OSRAM) 1987-10-01

Family

ID=27526479

Family Applications (2)

Application Number Title Priority Date Filing Date
DE19823249568 Granted DE3249568A1 (de) 1981-10-01 1982-09-30 Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs
DE19823236298 Granted DE3236298A1 (de) 1981-10-01 1982-09-30 Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten

Family Applications After (1)

Application Number Title Priority Date Filing Date
DE19823236298 Granted DE3236298A1 (de) 1981-10-01 1982-09-30 Krebszellen bekaempfende lymphocyten, verfahren zu deren herstellung und anti-krebsmittel, welche die lymphocyten enthalten

Country Status (19)

Country Link
AR (1) AR230731A1 (OSRAM)
AT (2) AT382080B (OSRAM)
AU (1) AU554858B2 (OSRAM)
BE (1) BE893704A (OSRAM)
CA (1) CA1195269A (OSRAM)
CH (2) CH655660B (OSRAM)
DD (2) DD209577A5 (OSRAM)
DE (2) DE3249568A1 (OSRAM)
DK (1) DK292182A (OSRAM)
FI (1) FI77157C (OSRAM)
FR (1) FR2513882B1 (OSRAM)
IL (1) IL66270A (OSRAM)
IT (1) IT1189305B (OSRAM)
MX (1) MX7437E (OSRAM)
NL (1) NL8202638A (OSRAM)
NO (1) NO161601C (OSRAM)
NZ (1) NZ201112A (OSRAM)
PT (1) PT75148B (OSRAM)
SE (1) SE8204058L (OSRAM)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60214737A (ja) * 1984-04-06 1985-10-28 Nippon Koutai Kenkyusho:Kk 糖鎖関連抗原の製造法
EP0334300A1 (en) * 1988-03-21 1989-09-27 Neorx Corporation The use of monoclonal antibodies and conjugates thereof as signals to direct sensitized effector cells to tumor sites

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1193378A (en) * 1967-04-11 1970-05-28 Rand Dev Corp Cancer Antigen Complexes
DE1943699A1 (de) * 1969-08-28 1971-03-04 Stiftung Onophrio Heilmittel mit proliferationshemmender Wirkung und Verfahren zur Herstellung dieses Heilmittels
YU34005B (en) * 1970-02-24 1978-10-31 Podvinec Srecko Process for obtaining bovine lymphatic gland extract
US4371515A (en) * 1978-12-26 1983-02-01 E-Y Laboratories, Inc. Method for forming an isolated lectin-immunological conjugate

Non-Patent Citations (9)

* Cited by examiner, † Cited by third party
Title
Biochem.Biophys.Res.Comm., 62, 144, 1975, 89, 448-455, 1979, 96, 1547-1553, 1980 *
Biochemistry, 13, 196-204, 1974 *
Br.J.Exp.Pathol., 27, 228-236, 1946 *
Carbohydrate Research, 51, 107-118, 1976 *
Cell, 18, 183-191, 1979 *
J.B.C., 250, 8518-8523, 1975 *
J.Biochem., 89, 473-481, 1981 *
Proc.Nat.Acad.Sci., 75, 2215-2219, 1978 *
Z.Immunitätsforsch., 138, 423-433, 1966 *

Also Published As

Publication number Publication date
AU8545882A (en) 1983-04-14
BE893704A (fr) 1982-10-18
IT8248724A0 (it) 1982-06-30
ATA354585A (de) 1989-08-15
NO822215L (no) 1983-04-05
NO161601C (no) 1989-09-06
IT1189305B (it) 1988-02-04
CA1195269A (en) 1985-10-15
AU554858B2 (en) 1986-09-04
AT390002B (de) 1990-03-12
FI77157B (fi) 1988-10-31
FR2513882A1 (fr) 1983-04-08
PT75148B (en) 1986-08-14
NO161601B (no) 1989-05-29
FI77157C (fi) 1989-02-10
SE8204058D0 (sv) 1982-06-30
DE3249568C2 (OSRAM) 1987-10-01
SE8204058L (sv) 1983-04-02
FR2513882B1 (fr) 1986-04-04
IL66270A0 (en) 1982-11-30
CH655661B (OSRAM) 1986-05-15
CH655660B (OSRAM) 1986-05-15
MX7437E (es) 1988-11-14
DD209577A5 (de) 1984-05-16
NL8202638A (nl) 1983-05-02
FI822325L (fi) 1983-04-02
DE3236298A1 (de) 1984-03-15
IT8248724A1 (it) 1983-12-30
AR230731A1 (es) 1984-06-29
NZ201112A (en) 1986-10-08
DK292182A (da) 1983-04-02
AT382080B (de) 1987-01-12
IL66270A (en) 1986-03-31
DE3236298C2 (OSRAM) 1987-09-24
ATA363782A (de) 1986-06-15
DD221917A5 (de) 1985-05-08
PT75148A (en) 1982-07-01
FI822325A0 (fi) 1982-06-29

Similar Documents

Publication Publication Date Title
DE3833319C2 (OSRAM)
DE69125735T2 (de) Verfahren zur Aktivierung der zytolytischen Wirkung von Lymphozyten unter Verwendung von anti-CD28-Antikörper
DE3227262A1 (de) Verfahren zur herstellung von target-zellen-lysis-faktor und dessen verwendung
DE3812605A1 (de) Immunregulative stoffe und stoffgemische zur aktiven beeinflussung des krankheitsverlaufes
WO1997017084A1 (de) Medikament, insbesondere zur modulation der immunantwort bei der bekämpfung von viren, tumoren, bakterien und parasiten
GB2082066A (en) Neem bark extracts possessing antineoplastic activities
DE69725317T2 (de) Implantierbare agarose-kollagenkügelchen enthaltende zellen, die ein diffusionsfähiges biologisches produkt bilden und ihre verwendung
DE69014543T2 (de) Multivalentes immunogen lmi.
PT1289535E (pt) Entidades apoptóticas para utilização no tratamento de desordens neurodegenerativas e de outras desordens neurológicas
DE60022499T2 (de) Neue therapeutische verwendung eines eine virale ansteckung modulierendes protein zur verhinderung von abstossung von fremdtransplantaten
GB2106935A (en) Cancer cell-combatting lymphocytes process, for the production thereof, and anticancer agents containing said lymphocytes
DE3249568A1 (de) Glykoverwandtes antigen, verfahren zu dessen herstellung und dessen verwendung zur bekaempfung von krebs
DE19961141A1 (de) Pharmazeutische Zusammensetzung aus Spinnengiften sowie deren Herstellung und Verwendung zur Behandlung von Tumorerkrankungen
CA2126108A1 (en) A method for treating kaposi's sarcoma and blocking or inhibiting vascular permeability
CH643459A5 (de) Mikrobielles zellwandgeruest mit adjuvans- und antitumorwirkung enthaltende, verfestigte pharmazeutische zubereitung und ihre herstellung.
DE69527640T2 (de) Zusammensetzungen die gemischte transferrine als wirkstoff für induktion von immunotoleranz gegen antigen enthalten
Alexander et al. Stimulants of cellular proliferation in wounds
EP0019167B1 (de) Arzneipräparat zur Behandlung von Carcinomen und Verfahren zu dessen Herstellung
DE69433472T2 (de) Recognin-vakzine
Bolton On the production of a specific gastrotoxic serum.—Preliminary communication.
KR880001758B1 (ko) 암세포에 대항하는 임파구의 제조방법
DE69430188T2 (de) Behandlung von hiv-infektionen mittels huminsäure
CA1201988A (en) Cancer cell-combatting lymphocytes, process for the production thereof and anticancer agents containing said lymphocytes
KR100209180B1 (ko) 아세만난을 포함하는 약제학적 조성물
JPH09176022A (ja) 腫瘍転移抑制剤

Legal Events

Date Code Title Description
AC Divided out of

Ref country code: DE

Ref document number: 3236298

Format of ref document f/p: P

OP8 Request for examination as to paragraph 44 patent law
AC Divided out of

Ref country code: DE

Ref document number: 3236298

Format of ref document f/p: P

AC Divided out of

Ref country code: DE

Ref document number: 3236298

Format of ref document f/p: P

D2 Grant after examination
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee